Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Poisoning by lidocaine |
Causative agent |
True |
Lidocaine (substance) |
Inferred relationship |
Some |
1 |
Lidocaine measurement |
Component |
True |
Lidocaine (substance) |
Inferred relationship |
Some |
1 |
Accidental lignocaine poisoning |
Causative agent |
False |
Lidocaine (substance) |
Inferred relationship |
Some |
|
Intentional lignocaine poisoning (disorder) |
Causative agent |
False |
Lidocaine (substance) |
Inferred relationship |
Some |
|
forgiftning med lidocain, uvist med hvilken hensigt |
Causative agent |
False |
Lidocaine (substance) |
Inferred relationship |
Some |
1 |
Lignocaine adverse reaction (disorder) |
Causative agent |
True |
Lidocaine (substance) |
Inferred relationship |
Some |
1 |
Allergy to lidocaine (finding) |
Causative agent |
False |
Lidocaine (substance) |
Inferred relationship |
Some |
|
Lignocaine overdose (disorder) |
Causative agent |
True |
Lidocaine (substance) |
Inferred relationship |
Some |
1 |
Accidental lignocaine overdose (disorder) |
Causative agent |
True |
Lidocaine (substance) |
Inferred relationship |
Some |
1 |
Intentional lidocaine overdose |
Causative agent |
True |
Lidocaine (substance) |
Inferred relationship |
Some |
1 |
overdosis af lidocain, uvist med hvilken hensigt |
Causative agent |
False |
Lidocaine (substance) |
Inferred relationship |
Some |
1 |
Lignocaine hydrochloride [antiarrhythmic] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine (substance) |
Inferred relationship |
Some |
|
Lignocaine hydrochloride [eye] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine (substance) |
Inferred relationship |
Some |
|
Product containing precisely lidocaine 20 milligram/1 gram conventional release cutaneous cream (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine (substance) |
Inferred relationship |
Some |
|
Lidocaine+prilocaine 2.5%/2.5% cream+occlusive dressing |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine (substance) |
Inferred relationship |
Some |
|
Product containing precisely lidocaine 25 milligram/1 gram and prilocaine 25 milligram/1 gram conventional release cutaneous cream (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine (substance) |
Inferred relationship |
Some |
|
Lignocaine HCl [anesthesia] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine (substance) |
Inferred relationship |
Some |
|
Lignocaine [generic addit] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine (substance) |
Inferred relationship |
Some |
|
lidocainhydrochlorid 100 mg/10 ml (1 %) i fyldt injektionssprøjte |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine (substance) |
Inferred relationship |
Some |
|
lidocainhydrochlorid 2 % til dental anvendelse, cylinderampul |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine (substance) |
Inferred relationship |
Some |
|
lidocainhydrochlorid 100 mg/5 ml (2 %) i fyldt injektionssprøjte |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine (substance) |
Inferred relationship |
Some |
|
lidocain + phenylephrin 5 %/0,5 % spray til topikal anvendelse, opløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine (substance) |
Inferred relationship |
Some |
|
lidocainhydrochlorid + adrenalin 0,5 %/1:200.000 injektionsvæske |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine (substance) |
Inferred relationship |
Some |
|
lidocainhydrochlorid 2 % halsspray |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine (substance) |
Inferred relationship |
Some |
|
Lidocaine hydrochloride 5 mg/g cutaneous gel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine (substance) |
Inferred relationship |
Some |
|
Lidocaine hydrochloride 10 mg/mL cutaneous gel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine (substance) |
Inferred relationship |
Some |
|
Product containing precisely lidocaine hydrochloride 20 milligram/1 milliliter conventional release cutaneous gel (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine (substance) |
Inferred relationship |
Some |
|
Product containing precisely lidocaine hydrochloride 50 milligram/1 gram conventional release gingival ointment (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine (substance) |
Inferred relationship |
Some |
|
Lidocaine 10 mg/actuation oromucosal spray |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine (substance) |
Inferred relationship |
Some |
|
Product containing precisely lidocaine hydrochloride 40 milligram/1 milliliter conventional release cutaneous solution (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine (substance) |
Inferred relationship |
Some |
|
lidocainhydrochlorid + adrenalin 2 %/1:80.000 cylinderampul |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine (substance) |
Inferred relationship |
Some |
|
lidokainhydrochlorid 4 % + fluoresceinnatrium 0,25 % øjendråber til engangsbrug |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine (substance) |
Inferred relationship |
Some |
|
Product containing epinephrine and lidocaine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Lidocaine (substance) |
Inferred relationship |
Some |
2 |
Product containing chlorhexidine and lidocaine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Lidocaine (substance) |
Inferred relationship |
Some |
2 |
Product containing fluorescein stain and lidocaine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Lidocaine (substance) |
Inferred relationship |
Some |
1 |
lidocainhydrochlorid + glucose |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine (substance) |
Inferred relationship |
Some |
|
Product containing lidocaine and prilocaine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Lidocaine (substance) |
Inferred relationship |
Some |
2 |
lidocain 1,5 % injektionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine (substance) |
Inferred relationship |
Some |
|
lidocainhydrochlorid + chlorhexidin 1 %/0,25 % gel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine (substance) |
Inferred relationship |
Some |
|
lidocainhydrochlorid + chlorhexidin 2 %/0,25 % gel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine (substance) |
Inferred relationship |
Some |
|
lidocainhydrochlorid 0,1 %/glucose 5 % infusionsvæske, opløsning, pose |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine (substance) |
Inferred relationship |
Some |
|
lidocainhydrochlorid 0,2 %/glucose 5 % infusionsvæske, opløsning, pose |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine (substance) |
Inferred relationship |
Some |
|
lidocainhydrochlorid 0,4 %/glucose 5 % infusionsvæske, opløsning, pose |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine (substance) |
Inferred relationship |
Some |
|
lidocainhydrochlorid 0,6 % + glucose 5 % infusionsvæske, opløsning, pose |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine (substance) |
Inferred relationship |
Some |
|
lidocainhydrochlorid 1 % steril injektionsvæske, opløsning, ampul |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine (substance) |
Inferred relationship |
Some |
|
lidocainhydrochlorid 2 % steril injektionsvæske, opløsning, ampul |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine (substance) |
Inferred relationship |
Some |
|
lidocainhydrochlorid 4 % injektionsvæske, opløsning, ampul |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine (substance) |
Inferred relationship |
Some |
|
Lidocainhydrochlorid, tung 5 % steril injektionsvæske, ampul |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine (substance) |
Inferred relationship |
Some |
|
lidocainhydrochlorid 0,5 % injektionsvæske, opløsning, ampul |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine (substance) |
Inferred relationship |
Some |
|
lidocainhydrochlorid 1 % injektionsvæske, opløsning, ampul |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine (substance) |
Inferred relationship |
Some |
|
lidocainhydrochlorid 2 % injektionsvæske, opløsning, ampul |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine (substance) |
Inferred relationship |
Some |
|
lidocainhydrochlorid 1 % injektionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine (substance) |
Inferred relationship |
Some |
|
lidocainhydrochlorid 2 % injektionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine (substance) |
Inferred relationship |
Some |
|
lidocainhydrochlorid + adrenalin 4 % næsedråber uden konserveringsmiddel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine (substance) |
Inferred relationship |
Some |
|
lidocainhydrochlorid 0,2 % + glucose 5 %, Polyfusor-flaske |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine (substance) |
Inferred relationship |
Some |
|
lidocainhydrochlorid 0,4 % + glucose 5 % i Polyfusor-flaske |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine (substance) |
Inferred relationship |
Some |
|
lidocainhydrochlorid 2 % opløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine (substance) |
Inferred relationship |
Some |
|
lidocainhydrochlorid 40 mg/ml (4 %) steril opløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine (substance) |
Inferred relationship |
Some |
|
lidocain til intravenøs anvendelse |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine (substance) |
Inferred relationship |
Some |
|
lidocaininjektionsvæske til lokal anvendelse |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine (substance) |
Inferred relationship |
Some |
|
lidocain til topikal anvendelse |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine (substance) |
Inferred relationship |
Some |
|
lidocainhydrochlorid 1 %/adrenalin 1:200.000 injektionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine (substance) |
Inferred relationship |
Some |
|
lidocainhydrochlorid 2 %/adrenalin 1:200.000 injektionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine (substance) |
Inferred relationship |
Some |
|
Product containing lidocaine and phenylephrine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Lidocaine (substance) |
Inferred relationship |
Some |
2 |
lidocainhydrochlorid 1,5 %/adrenalin 1:200.000 injektionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine (substance) |
Inferred relationship |
Some |
|
lidocainhydrochlorid 2 %/adrenalin 1:500.000 injektionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine (substance) |
Inferred relationship |
Some |
|
lidocainhydrochlorid 2 %/adrenalin 1:100.000 injektionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine (substance) |
Inferred relationship |
Some |
|
Product containing precisely lidocaine hydrochloride 30 milligram/1 milliliter conventional release cutaneous cream (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine (substance) |
Inferred relationship |
Some |
|
lidocainhydrochlorid 100 mg/ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine (substance) |
Inferred relationship |
Some |
|
lidocain 46,1 mg/enhed |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine (substance) |
Inferred relationship |
Some |
|
lidocainhydrochlorid 12 mg/dosis, spray |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine (substance) |
Inferred relationship |
Some |
|
Lidocaine 50 microgram/mg cutaneous patch |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine (substance) |
Inferred relationship |
Some |
|
lidocainhydrochlorid 1,5 % injektionsvæske, opløsning, ampul |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine (substance) |
Inferred relationship |
Some |
|
lidocainhydrochlorid 0,5 % injektionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine (substance) |
Inferred relationship |
Some |
|
lidocainhydrochlorid 40 mg/ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine (substance) |
Inferred relationship |
Some |
|
lidocainhydrochlorid 4 % opløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine (substance) |
Inferred relationship |
Some |
|
lidocain 5 % opløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine (substance) |
Inferred relationship |
Some |
|
Lidocaine hydrocarbonate 10mg/mL injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine (substance) |
Inferred relationship |
Some |
|
dextrose + lidocainhydrochlorid 75 mg/50 mg |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine (substance) |
Inferred relationship |
Some |
|
adrenalin 10 µg + lidocainhydrochlorid 20 mg injektionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine (substance) |
Inferred relationship |
Some |
|
adrenalin 20 µg + lidocainhydrochlorid 20 mg injektionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine (substance) |
Inferred relationship |
Some |
|
adrenalin 10 µg + lidocainhydrochlorid 10 mg injektionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine (substance) |
Inferred relationship |
Some |
|
Epinephrine + lidocaine hydrochloride 10mcg/20mg injecti |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine (substance) |
Inferred relationship |
Some |
|
Epinephrine + lidocaine hydrochloride 20mcg/20mg |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine (substance) |
Inferred relationship |
Some |
|
adrenalin 5 µg + lidocainhydrochlorid 15 mg injektionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine (substance) |
Inferred relationship |
Some |
|
adrenalinbitartrat 5 µg + lidocainhydrochlorid 10 mg injektionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine (substance) |
Inferred relationship |
Some |
|
Epinephrine bitartrate + lidocaine hydrochloride 10mcg/20mg inj |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine (substance) |
Inferred relationship |
Some |
|
Epinephrine bitartrate + lidocaine hydrochloride 20mcg/20mg inj |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine (substance) |
Inferred relationship |
Some |
|
Lidocaine + prilocaine 25mg/25mg cream |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine (substance) |
Inferred relationship |
Some |
|
lidocainhydrochlorid 5 %/glucose 7,5 % injektionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine (substance) |
Inferred relationship |
Some |
|
lidocainhydrochlorid 1 %/adrenalin 1:100.000 injektionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine (substance) |
Inferred relationship |
Some |
|
dextrose 7,5 % wt/wt/lidocainhydrochlorid 1,5 % wt/wt injektionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine (substance) |
Inferred relationship |
Some |
|
Product containing lidocaine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Lidocaine (substance) |
Inferred relationship |
Some |
1 |
methylprednisolonacetat 80 mg/2 ml+ lidocainhydrochlorid 20 mg/2 ml injektionsvæske |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine (substance) |
Inferred relationship |
Some |
|
methylprednisolonacetat 40/1 ml + lidocainhydrochlorid 10 mg/1 ml injektionsvæske |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine (substance) |
Inferred relationship |
Some |
|
Product containing lidocaine and methylprednisolone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Lidocaine (substance) |
Inferred relationship |
Some |
2 |
oxytetracyclin + lidocain 50 mg/ml/2 % injektionsvæske, 2 ml ampul |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine (substance) |
Inferred relationship |
Some |
|
oxytetracyclin 50 mg/ml + lidocain 2 % injektionsvæske, 10 ml ampul |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine (substance) |
Inferred relationship |
Some |
|
oxytetracyclin + lidocain 125 mg/ml/2 % injektionsvæske, 2 ml ampul |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine (substance) |
Inferred relationship |
Some |
|
Product containing lidocaine and oxytetracycline (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Lidocaine (substance) |
Inferred relationship |
Some |
2 |
Domiphen bromide+lidocaine hydrochloride |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine (substance) |
Inferred relationship |
Some |
|